ICD-10 F2-6, F8-F9
Conditions
Interventions
Group 1: Intervention group: Participants receive standard child and adolescent psychiatric psychotherapeutic treatment (TAU) and participate in the HOP program (3 weekly sessions à 120 minutes + 1 bo
manual from Mulfinger et al., 2022, version January 2025).
Group 2: Control group: Participants receive standard child and adolescent psychiatric psychotherapeutic treatment (TAU) and participate in t
manual from Jensen et al., 2023, modified version for adolescents from Hörger et al. 2025, version February 2025).
Sponsors
Universität Ulm
Eligibility
Sex/Gender
All
Age
14 Years to 21 Years
Inclusion criteria
Inclusion criteria: - at least one current mental disorder according to ICD-10 - current inpatient, day clinic or outpatient child/adolescent psychiatric or psychotherapeutic treatment - age 14-21 years - ability to give written informed consent - written informed consent of parents or legal guardians - sufficient German language skills (required for group participation and self-report measures)
Exclusion criteria
Exclusion criteria: - Diagnosis that is limited to substance-use disorder (ICD-10: F1) without non-substance-related current psychiatric comorbidity - intellectual disability (IQ < 70; ICD-10: F7) - organic disorder (ICD-10: F0) - acute psychotic symptoms or acute suicidality - previous participation in the HOP program
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (1) Stigma Stress Scale (SSS) at T1, 3 weeks after baseline or after the third group session (8 Items, Rüsch et al. 2009) (2) Health-related quality of life (KIDSCREEN-10) at T2, 6 weeks after baseline or after the booster-session (10 Items, Ravens-Sieberer et al. 2010) | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Quality of Life Measure (KIDSCREEN-10) at T1 as well as T3, 30 weeks after baseline, and T4, 56 weeks after baseline (10 Items, Ravens-Sieberer et al. 2010) (2) Stigma-Stress Scale (SSS) at T2 and T3 (8 Items; Rüsch et al. 2009) (3) Self-stigma of Mental Illness Scale - Short Form (SSMIS-SF), Subscale "apply to self" at T1, T2, T3 (5 Items; Corrigan et al. 2012) (4) Empowerment (ES) - Subscale Self-Efficacy at T1, T2, T3 (9 Items; Rogers et al. 1997) (5) General Help Seeking Questionnaire (GHSQ) - Subscale professional help at T1, T2, T3 (4 Items; Wilson et al. 2005) (6) Self-Identified Stage of Recovery (SISR) - Part B at T1, T2, T3 (4 Items; Andresen et al. 2010) (7) Depressive Symptoms via the German Version of the Center for Epidemiologic Studies-Depression Scale (CES-D/ADS) at T1, T2, T3 (15 Items; Hautzinger & Bailer, 1993) (8) Perceived group cohesion via the Group Cohesiveness Scale (GCS) at T1 and T2 (7 Items; Wongpakaran et al. 2013) (9) Secrecy und Social Withdrawal at T1, T2, T3 (12 Items; Link et al. 1991) (10) Cost-Utility Data at T3 and T4 via the Child and Adolescent Service Receipt Inventory – German Version (CAMSHRI-DE; Salize & Kilian, 2010) (11) Health status at T3 and T4 via the European Quality of Life Questionnaire (EQ-5D-5L; EuroQol Group, 1990) (12) Pediatric Symptom Checklist-Youth-17, Self-report, at T1, T2 and T3 (PSC-17-Y; Bergmann et al., 2020) (13) Self-labeling, shame and disclosure-related distress at T1, T2 and T3 (5 Items; Rüsch et al., 2014, Psychiatr Serv; Rüsch et al., 2014, BJPsych) (14) Qualitative Interview of participants on the implementation and acceptability of HOP | — |
Countries
Germany
Contacts
Public ContactNicolas Rüsch
Klinik für Psychiatrie und Psychotherapie II der Universität Ulm am Bezirkskrankenhaus Günzburg, Sektion Public Mental Health
Outcome results
None listed